UTHR NASDAQ
United Therapeutics Corporation
1W: +9.2%
1M: +24.7%
3M: +13.2%
YTD: +19.4%
1Y: +39.1%
3Y: +162.5%
5Y: +221.6%
$589.16
-3.68 (-0.62%)
Weekly Expected Move ±8.0%
$494
$541
$588
$634
$681
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' 16.42.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships0
As Filer
counterparties named
7
As Counterparty
mentioned by others
2021-08-16
Earliest Filing
2025-08-27
Latest Filing
Mentioned As Counterparty
7 mentionsOther companies that named UTHR in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| MNKD MANNKIND CORP | partner | Collaboration partner exercising an option to expand product scope under a license agreement with MannKind. | 2025-08-27 | View |
| MNKD MANNKIND CORP | partner | Original licensee under the License Agreement dated September 3, 2018, as amended. | 2024-01-02 | View |
| LQDA Liquidia Corp | partner | Counterparty in ongoing patent litigation affecting financing tranches | 2023-06-28 | View |
| LQDA Liquidia Corp | partner | Counterparty in ongoing patent litigation triggering potential funding | 2023-01-09 | View |
| MNKD MANNKIND CORP | supplier | Amendment to commercial supply agreement extending term and modifying non-renewal notification periods. | 2021-10-18 | View |
| MNKD MANNKIND CORP | supplier | MannKind entered into a commercial supply agreement for MannKind to manufacture and supply Tyvaso DPI and BluHale inhala | 2021-08-16 | View |
| MNKD MANNKIND CORP | supplier | MannKind entered into a commercial supply agreement to manufacture and supply Tyvaso DPI and BluHale devices to United T | 2021-08-16 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-22 | Other Events; Exhibits | View | |
| 2026-10-14 | Other Events; Exhibits | View | |
| 2026-09-08 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-07-23 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-06-29 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-03-30 | Other Events; Exhibits | View | |
| 2026-03-09 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2026-03-02 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-25 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-22 | Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or | View | |
| 2025-10-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-02 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-01 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-07-30 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-27 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-04-30 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-28 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of | Agreement | View |
| 2025-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR